STAT+: FDA approves Ultragenyx gene therapy

🇺🇸 STAT News Health (US) —
STAT+: FDA approves Ultragenyx gene therapy

AI Summary

The FDA has approved a gene therapy from Ultragenyx, marking a significant development in treatment for ultra-rare diseases. This approval also validates ongoing mRNA research in the biotech industry.

Regeneron wins ultra-rare disease drug approval, a validating win for mRNA research, and more biotech news from The Readout

Markets Deals Health AI & Tech FDA approval gene therapy Ultragenyx mRNA research ultra-rare diseases biotech drug approval

Read original source →